Latest Disclosure Policy News

Ovanti Limited has addressed ASX concerns over its relationship with BNPLPay, clarifying key personnel roles, ownership structures, and cryptocurrency exposure tied to its Licence Agreement.

Lycaon Resources has addressed an ASX price query, confirming no undisclosed information influenced recent trading and releasing assay results from its Stansmore Project drilling program.

AJ Lucas Group Limited has responded to an ASX query about a recent sharp rise in its share price, confirming no undisclosed information exists to explain the trading activity and affirming compliance with listing rules.

Arafura Rare Earths Limited has acknowledged a breach of ASX Listing Rule 15.7 following premature media disclosure of a $200 million investment commitment from the National Reconstruction Fund Corporation. The company outlines corrective steps to prevent future compliance lapses.

Nimy Resources has addressed an ASX inquiry regarding recent spikes in its share price and trading volume, confirming no undisclosed information but highlighting ongoing work on its maiden JORC Exploration Target for gallium.

Wellard Limited has disclosed the binding sale of its last livestock vessel, the M/V Ocean Drover, for US$50 million, with plans to return the net proceeds to shareholders pending approval.

Artrya Limited has responded to an ASX price query following a notable surge in its share price, confirming no undisclosed information and adherence to continuous disclosure rules.

Resources & Energy Group Ltd (REZ) has clarified recent trading activity in its shares, attributing the surge to a significant rise in gold prices rather than undisclosed information. The company remains focused on its Maranoa gold recovery program, with further results pending.

Latrobe Magnesium Limited has responded to an ASX price query, denying any undisclosed information that could explain the recent sharp drop in its share price and surge in trading volume.

EBR Systems Inc. has responded to ASX's price query, denying any undisclosed information behind recent trading spikes and confirming compliance with listing rules. The company also flagged an upcoming FDA inspection announcement.